Flurazepam
Discover related
3 sources
🧬 Receptor activity
| Target | Action | Affinity | Source | |
|---|---|---|---|---|
| GABA-A receptor alpha-1/beta-2/gamma-2 (GABRA1) | Positive allosteric modulator | 8.1 IC50 | DRUGCENTRAL | TargetGABA-A receptor alpha-1/beta-2/gamma-2 (GABRA1) ActionPositive allosteric modulator Affinity8.1 IC50 SourceDRUGCENTRAL |
| Solute carrier family 22 member 2 (SLC22A2) | — | 4.222 IC50 | DRUGCENTRAL | TargetSolute carrier family 22 member 2 (SLC22A2) Action— Affinity4.222 IC50 SourceDRUGCENTRAL |
External links
PubChem 3393 ↗CAS 17617-23-1 ↗ChEBI CHEBI:5128 ↗ChEMBL CHEMBL968 ↗KEGG D00329 ↗DrugBank DB00690 ↗ChemSpider ↗ChEBI/ChEMBL ↗ChEBI/ChEMBL ↗Guide to Pharmacology ↗NIH ↗NIH ↗NIH ↗NIH ↗DrugBank ↗ChEBI/ChEMBL ↗NIH ↗CAS 192725-17-0 ↗PsychonautWiki ↗Erowid ↗Experience reports (PiHKAL) ↗Experience reports (TiHKAL) ↗
Source: DrugCentral — Flurazepam ↗
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.